10x Genomics, Inc.
TXG
株式のランク
#2231
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
株価
$69.74
最終同期: 2026-10-16
時価総額
$9.09B
変化（1日）
-3.67%
変化（1年）
489.48%
国
US
取引 10x Genomics, Inc. (TXG)
カテゴリー
Healthcare
10x Genomics, Inc.（TXG）の営業利益率
October 2026 時点の営業利益率 TTM: -14.33%
10x Genomics, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は -14.33% です。2023 年末時点では -42.88% でした。
10x Genomics, Inc. の営業利益率の履歴（2017 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | -14.33% | -55.01% |
| 2024 | -31.85% | -25.72% |
| 2023 | -42.88% | 31.86% |
| 2022 | -32.52% | 201.39% |
| 2021 | -10.79% | -62.21% |
| 2020 | -28.55% | 141.54% |
| 2019 | -11.82% | -84.39% |
| 2018 | -75.70% | 192.84% |
| 2017 | -25.85% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 12.70% | -100.89% |
US
|
|
| 74.94% | -105.23% |
AU
|
|
| 3.33% | -100.23% |
US
|
|
| -19.76% | -98.62% |
US
|
|
| 0.00% | - |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。